ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Netherlands Cancer Institute
Amsterda, HolandaPublicacións en colaboración con investigadores/as de Netherlands Cancer Institute (2)
2015
-
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
Annals of Oncology, Vol. 26, Núm. 7, pp. 1280-1291
2008
-
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Cancer Research, Vol. 68, Núm. 15, pp. 6084-6091